Floatz logo

Cytosin-Arabinosid

Chronic Neuropathic Pain

Stanford UniversityPhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Chronic Neuropathic Pain cohort.

Asset / SponsorPhaseRating
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Boston Children's Hospital
Phase 4BB
NEPENTHE
Nova Scotia Health Authority
Phase 4BB
Amitriptyline
UMC Utrecht
Phase 4BB
Naltrexone
Emory University
Phase 4BB
METHADONE
Nova Scotia Health Authority
Phase 4BB

View all 10 →

Same molecule, other indications

Cytosin-Arabinosid is also rated in:

acute promyelocytic leukemiaDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →